Apatinib-impurities | Pharmaffiliates

apatinib

Apatinib is a novel, small molecule, selective vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and is the second anti-angiogenic drug to be approved in China for the treatment of advanced or metastatic gastric cancer.Reference standards of Apatinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => rac cis-3-Hydroxy Apatinib-d4 3-O-β-D-Glucuronide
    [catalogue_number] => PA STI 047310
    [category_ids] => ,80,95,71,98,76,75,78,70,82,117,
    [chemical_name] => 
    [weight] => 593.62
    [form] => C30H27D4N5O8
    [cas] => NA
    [pslug] => rac-cis-3-hydroxy-apatinib-d4-3-o-beta-d-glucuronide-pasti047310
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 047310

rac cis-3-Hydroxy Apatinib-d4 3-O-β-D-Glucuronide


  • Catalogue No.:PA STI 047310

  • CAS :

    NA

  • Molecular Formula : C30H27D4N5O8

  • Molecular Weight : 593.62